NCT00818402

Completed

Non-small Cell Lung Cancer and Quality of Life

University of Turku Source

Compare

Other study identifiers

Sponsor study identifier

SILKE-ETMK:47/180/2008

Study Type

observational

Actual enrollment (reported)

130

Locations

0 countries

Sites

N/A

Timeline

Study Start

August 2008

Date type not reported

This date has not been verified as actual or estimated.

Primary Completion

February 2012

Actual (reported)

Study Completion

February 2012

Actual (reported)

Brief Summary

The principal objective is to study clinical observations, symptoms and quality of life of non-small-cell lung cancer (NSCLC) patients undergoing specific non-operative treatment for cancer, including chemotherapy and radiotherapy.

Registry Overview

Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.

Recruitment status: completed
Actual enrollment (reported): 130 participants
Study completion date: February 2012
Actual (reported)
Listed locations: 0 countries · 0 sites

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.

Study Start
August 2008
Date type not reported
This date has not been verified as actual or estimated.
First Submitted
January 5, 2009
Actual (reported)
First Posted
January 7, 2009
Actual (reported)
Primary Completion
February 2012
Actual (reported)
Study Completion
February 2012
Actual (reported)

Last Updated: May 29, 2015
Status Verified: May 2015
Last Update Submitted: May 28, 2015

Conditions

Non Small Cell Lung Cancer

Keywords

Quality of lifesymptoms

Study Arms (1)

Non-small cell lung cancer patients

Eligibility Criteria

Age18 Years+

Sexall

Healthy VolunteersNo

Age GroupsAdult (18-64), Older Adult (65+)

Sampling MethodNon-Probability Sample

Study Population

The patients treated in the clinic of respiratory medicine in Turku, Finland

You may qualify if:

Patients with verified NSCLC
after the NSCLC diagnosis has been confirmed prior to first chemotherapy or radiotherapy
Finnish speaking patients
aged 18 years or more
Written informed consent has to be signed

You may not qualify if:

Sponsors & Collaborators

University of Turku
Otherlead

Biospecimen

Retention: SAMPLES WITH DNA

whole blood

MeSH Terms

Conditions

Carcinoma, Non-Small-Cell Lung

Condition Hierarchy (Ancestors)

Carcinoma, BronchogenicBronchial NeoplasmsLung NeoplasmsRespiratory Tract NeoplasmsThoracic NeoplasmsNeoplasms by SiteNeoplasmsLung DiseasesRespiratory Tract Diseases

Enrollment

130 participants (actual enrollment reported by the registry).

Study Design

Study Type: observational
Observational Model: CASE ONLY
Time Perspective: PROSPECTIVE
Sponsor Type: OTHER
Responsible Party: PRINCIPAL INVESTIGATOR
PI Title: MD

Study Record Dates

First Submitted

January 5, 2009

First Posted

January 7, 2009

Study Start

August 2008

Date type not reported

This date has not been verified as actual or estimated.

NCT04257864

Bevacizumab Versus Docetaxel/Erlotinib on Tumor Metrics in Patients With Previously Untreated Advanced Non Small Cell Lung Cancer

Completed

NCT00654758

A Phase 1b Study With Volociximab in Combination With Carboplatin and Paclitaxel in First-line, Advanced Non-Small Cell Lung Cancer (NSCLC)

Phase 1Completed

NCT02595450

A Non-interventional Trial of Erlotinib (Tarceva) Metastatic Non-small Cell Lung Cancer

Completed

NCT01005680

A Study Comparing Two Different Chemotherapy Types in Chinese Patients With Advanced Non Small Cell Lung Cancer

Phase 3Completed

NCT00380718

Chemotherapy for Patients With Non-Small Cell Lung Cancer

Phase 4Completed

NCT00531401

Study of Salirasib to Treat Non-Small Cell Lung Cancer

Phase 2Completed

Patients not consenting to participate in the study
patients not able to communicate sufficiently
cancer type is other than non-small-cell lung cancer

Contact the study team to confirm eligibility.

Primary Completion

February 2012

Actual (reported)

Study Completion

February 2012

Actual (reported)

Last Updated

May 29, 2015

Record last verified: 2015-05

Source record

Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.

Source: ClinicalTrials.gov.

JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.

Registry identifier: NCT00818402
Data provider: ClinicalTrials.gov
Source updated: 2015-05-29
Normalization version: ctgov-legacy-1

Open registry record

Source retrieved: 2026-10-25 22:27:29 UTC

Brief Summary

Registry Overview

Trial Relationships

Related Scientific Literature

Study Timeline

Study Start

First Submitted

First Posted

Primary Completion

Study Completion

Conditions

Keywords

Study Arms (1)

Non-small cell lung cancer patients

Eligibility Criteria

You may qualify if:

You may not qualify if:

Sponsors & Collaborators

Biospecimen

MeSH Terms

Conditions

Condition Hierarchy (Ancestors)

Enrollment

Study Design

Study Record Dates

Source record